Nippon India Nifty Pharma ETF vs Tata NIFTY Midsmall Healthcare Index Fund
Direct Plan, Growth option · Data as on 30-10-2026
Nippon India Nifty Pharma ETF is a mutual fund and Tata NIFTY Midsmall Healthcare Index Fund is a mutual fund. In the year to 30-10-2026, Nippon India Nifty Pharma ETF (Direct) returned 22.1% and Tata NIFTY Midsmall Healthcare Index Fund (Direct) returned 16.7%. Nippon India Nifty Pharma ETF charges 0.23% a year and Tata NIFTY Midsmall Healthcare Index Fund 0.58% (Direct plans). Their portfolios overlap 43.1%: they hold 14 of the same securities.
Nippon India Nifty Pharma ETF
- 1 year return
- 22.1%
- Expense ratio
- 0.23%
- NAV
- ₹27.89
Tata NIFTY Midsmall Healthcare Index Fund
- 1 year return
- 16.7%
- Expense ratio
- 0.58%
- NAV
- ₹15.24
Which is better, Nippon India Nifty Pharma ETF or Tata NIFTY Midsmall Healthcare Index? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Nippon India Nifty Pharma ETF returned more over 1 year: 22.1% against 16.7%.
- Nippon India Nifty Pharma ETF costs less: 0.23% a year against 0.58% (Direct plans).
- Nippon India Nifty Pharma ETF fell less in its worst fall since 30-04-2024: −16.6% against −17.5%.
- Nippon India Nifty Pharma ETF holds more in large companies: 46.3% of the fund in large caps against 0.0%.
- Nippon India Nifty Pharma ETF is the larger fund: ₹1,736 Cr against ₹221 Cr.
- Their portfolios overlap 43.1%: 14 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Nippon India Nifty Pharma ETF | Tata NIFTY Midsmall Healthcare Index Fund |
|---|---|---|
| Fund house | Nippon India Mutual Fund | Tata Mutual Fund |
| Category | Not available | Not available |
| AUM | ₹1,736 Cr (30-09-2026) | ₹221 Cr (30-09-2026) |
| NAV | ₹27.89 (Direct) | ₹15.24 (Direct) |
| Expense ratio (Direct) | 0.23% | 0.58% |
| Expense ratio (Regular) | Not available | 1.14% |
| Riskometer | Not available | Not available |
| Benchmark | Not available | Not available |
| Launch date | Not available | Not available |
| Minimum investment | Not available | Not available |
| Lock in | Not available | Not available |
| Fund managers | Not available | Not available |
| Exit load | Not available | Not available |
Nippon India Nifty Pharma ETF vs Tata NIFTY Midsmall Healthcare Index: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Nippon India Nifty Pharma ETF (Direct) | +2.58% | +2.95% | +16.84% | +22.08% | +22.94% | +14.91% | -- |
| Tata NIFTY Midsmall Healthcare Index Fund (Direct) | +1.83% | +0.14% | +15.38% | +16.74% | -- | -- | -- |
Nippon India Nifty Pharma ETF vs Tata NIFTY Midsmall Healthcare Index: Year-wise Returns
| Year | Nippon India Nifty Pharma ETFNippon India Nifty Pharma ETF | Tata NIFTY Midsmall Healthcare IndexTata NIFTY Midsmall Healthcare Index |
|---|---|---|
| 2026to date | +19.82% | +18.20% |
| 2025 | −2.46% | −0.92% |
| 2024 | +39.59% | -- |
| 2023 | +34.44% | -- |
| 2022 | −10.86% | -- |
Nippon India Nifty Pharma ETF vs Tata NIFTY Midsmall Healthcare Index: Rolling Returns
Every holding period of both funds, against Nifty Pharma TRI, the benchmark of Nippon India Nifty Pharma ETF
Rolling returns
Every 1-year holding period, 372 of them, one for each trading day from 30-04-2025 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
Nippon India Nifty Pharma ETF (Direct)
Tata NIFTY Midsmall Healthcare Index Fund (Direct)
Nifty Pharma TRI
to
Jun 2025Sept 2024
to
Sept 2025Dec 2024
to
Dec 2025Mar 2025
to
Mar 2026Jun 2025
to
Jun 2026Sept 2025
to
Sept 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nippon India Nifty Pharma ETF | 17.7 | 16.9 | 16.1 | 24.2 | 15.9 | 8.6 | 0.5 | 8.8% | 9.7% | −8.2% | 25.9% | 1% |
| Tata NIFTY Midsmall Healthcare Index | 5.1 | 17.8 | 15.9 | 22.1 | 27.0 | 11.9 | 0.3 | 11.6% | 13.0% | −2.0% | 25.8% | 64% |
| Nifty Pharma TRI | 17.7 | 16.7 | 15.6 | 21.8 | 18.3 | 9.1 | 0.8 | 9.1% | 10.0% | −8.0% | 26.2% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is Nifty Pharma TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 30-04-2024. Past returns do not promise future returns.
Nippon India Nifty Pharma ETF vs Tata NIFTY Midsmall Healthcare Index: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 01-04-2024 to 30-10-2026: 31 instalments, ₹3,10,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| Nippon India Nifty Pharma ETFNippon India Nifty Pharma ETF (Direct) | ₹3,10,000 | ₹3,81,148 | ₹71,148 | 16.3% |
| Tata NIFTY Midsmall Healthcare IndexTata NIFTY Midsmall Healthcare Index Fund (Direct) | ₹3,10,000 | ₹3,80,959 | ₹70,959 | 16.3% |
Nippon India Nifty Pharma ETFNippon India Nifty Pharma ETF (Direct)
Tata NIFTY Midsmall Healthcare IndexTata NIFTY Midsmall Healthcare Index Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
Nippon India Nifty Pharma ETF vs Tata NIFTY Midsmall Healthcare Index: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Nippon India Nifty Pharma ETF (Direct) | Tata NIFTY Midsmall Healthcare Index Fund (Direct) |
|---|---|---|
| Return (CAGR) | +22.08% | +16.74% |
| Standard deviation | 14.13% | 15.36% |
| Sharpe ratio | 1.19 | 0.75 |
| Sortino ratio | 1.86 | 1.11 |
| Maximum drawdown | −7.5% (01-02-2026) | −10.4% (23-10-2026) |
| Beta | 1.00 | 1.00 |
| Alpha | −0.28% | −0.64% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Nippon India Nifty Pharma ETF (Direct) | Tata NIFTY Midsmall Healthcare Index Fund (Direct) |
|---|---|---|
| Return (CAGR) | +13.22% | +17.98% |
| Standard deviation | 15.07% | 15.90% |
| Sharpe ratio | 0.50 | 0.76 |
| Sortino ratio | 0.72 | 1.07 |
| Maximum drawdown | −21.0% (13-03-2023) | −17.5% (28-02-2025) |
| Beta | 1.00 | 1.00 |
| Alpha | −0.26% | −0.83% |
From daily NAVs, 06-07-2021 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Nippon India Nifty Pharma ETF (Direct)
Tata NIFTY Midsmall Healthcare Index Fund (Direct)
Nifty Pharma TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Nippon India Nifty Pharma ETF (Direct) | −16.6% | 09-10-2024 | 28-02-2025 | 06-05-2026 | 14 months | −0.3% |
| Tata NIFTY Midsmall Healthcare Index Fund (Direct) | −17.5% | 07-01-2025 | 28-02-2025 | 15-07-2025 | 5 months | −2.4% |
| Nifty Pharma TRI | −16.5% | 09-10-2024 | 28-02-2025 | 05-05-2026 | 14 months | −0.2% |
From daily values since 30-04-2024, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Nippon India Nifty Pharma ETF (Direct)
Tata NIFTY Midsmall Healthcare Index Fund (Direct)
Nifty Pharma TRI
Against Nifty Pharma TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| Nippon India Nifty Pharma ETF (Direct) | 99% | 100% | 0.03% |
| Tata NIFTY Midsmall Healthcare Index Fund (Direct) | 102% | 92% | 6.27% |
From month-end values since 30-04-2024. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
Nippon India Nifty Pharma ETF vs Tata NIFTY Midsmall Healthcare Index: Portfolio Overlap
From each fund's latest monthly portfolio: Nippon India Nifty Pharma ETF, September 2026; Tata NIFTY Midsmall Healthcare Index Fund, September 2026
Holdings in common
- Overlap
- 43.1%
- Held by both
- 14
- Only in Nippon India Nifty Pharma ETF
- 6
- Only in Tata NIFTY Midsmall Healthcare Index
- 16
| Security | % of Nippon India Nifty Pharma ETF | % of Tata NIFTY Midsmall Healthcare Index |
|---|---|---|
| Laurus Labs Limited | 7.82% | 11.84% |
| Lupin Limited | 5.00% | 7.57% |
| Aurobindo Pharma Limited | 4.69% | 7.09% |
| Glenmark Pharmaceuticals Limited | 3.56% | 5.40% |
| Alkem Laboratories Limited | 3.16% | 4.78% |
| Mankind Pharma Limited | 2.88% | 4.36% |
| IPCA Laboratories Limited | 2.71% | 4.11% |
| Biocon Limited | 2.62% | 3.96% |
| Gland Pharma Limited | 2.34% | 3.55% |
| Sai Life Sciences Limited | 2.14% | 3.24% |
| Wockhardt Limited | 1.77% | 2.68% |
| Ajanta Pharma Limited | 1.67% | 2.53% |
| Abbott India Limited | 1.43% | 2.17% |
| Piramal Pharma Limited | 1.30% | 1.97% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 43.1% means 43.1% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Nippon India Nifty Pharma ETF
| Security | % of fund |
|---|---|
| Sun Pharmaceutical Industries Limited | 19.50% |
| Divi's Laboratories Limited | 11.97% |
| Cipla Limited | 7.68% |
| Dr. Reddy's Laboratories Limited | 7.62% |
| Torrent Pharmaceuticals Limited | 7.16% |
Largest holdings only in Tata NIFTY Midsmall Healthcare Index Fund
| Security | % of fund |
|---|---|
| FORTIS HEALTHCARE LTD | 6.16% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | 3.06% |
| ASTER DM QUALITY CARE LTD | 2.86% |
| NEULAND LABORATORIES LTD | 2.83% |
| ACUTAAS CHEMICALS LTD | 2.61% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Nippon India Nifty Pharma ETF | Tata NIFTY Midsmall Healthcare Index |
|---|---|---|
| Equity | 99.9% | 100.1% |
| Debt | 0.0% | 0.0% |
| Cash and others | 0.1% | -0.1% |
Market cap of stocks
| Market cap | Nippon India Nifty Pharma ETF | Tata NIFTY Midsmall Healthcare Index |
|---|---|---|
| Large Cap | 46.3% | 0.0% |
| Mid Cap | 46.1% | 67.9% |
| Small Cap | 7.5% | 32.2% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Nippon India Nifty Pharma ETF | Tata NIFTY Midsmall Healthcare Index |
|---|---|---|
| Pharmaceuticals & Biotechnology | 99.9% | 79.9% |
| Healthcare Services | 0.0% | 19.3% |
| Healthcare Equipment & Supplies | 0.0% | 1.0% |
The six largest sectors of each fund's stocks, % of the fund.
Nippon India Nifty Pharma ETF vs Tata NIFTY Midsmall Healthcare Index: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Nippon India Nifty Pharma ETF | Tata NIFTY Midsmall Healthcare Index Fund |
|---|---|---|
| Total expense ratio (Direct) | 0.23% | 0.58% |
| Base expense ratio (Direct) | 0.18% | 0.37% |
| Total expense ratio (Regular) | Not available | 1.14% |
| Base expense ratio (Regular) | 0.00% | 0.90% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
Nippon India Nifty Pharma ETF vs Tata NIFTY Midsmall Healthcare Index Fund: Frequently Asked Questions
What is the difference between Nippon India Nifty Pharma ETF and Tata NIFTY Midsmall Healthcare Index Fund?
Nippon India Nifty Pharma ETF is a mutual fund, Tata NIFTY Midsmall Healthcare Index Fund is a mutual fund, run by Nippon India Mutual Fund and Tata Mutual Fund. Their portfolios overlap 43.1%. Nippon India Nifty Pharma ETF charges 0.23% a year and Tata NIFTY Midsmall Healthcare Index Fund 0.58%.
Which has given higher returns, Nippon India Nifty Pharma ETF or Tata NIFTY Midsmall Healthcare Index Fund?
Over 1 year: Nippon India Nifty Pharma ETF +22.08%, Tata NIFTY Midsmall Healthcare Index Fund +16.74%. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, Nippon India Nifty Pharma ETF or Tata NIFTY Midsmall Healthcare Index Fund?
Nippon India Nifty Pharma ETF charges less: 0.23% a year against 0.58%. These are the Direct plans' total expense ratios reported to AMFI.
How much do Nippon India Nifty Pharma ETF and Tata NIFTY Midsmall Healthcare Index Fund overlap?
43.1%. They hold 14 of the same securities, the largest shared ones being LAURUSLABS, LUPIN, AUROPHARMA. From each fund's latest monthly portfolio.
Can I invest in both Nippon India Nifty Pharma ETF and Tata NIFTY Midsmall Healthcare Index Fund?
Yes. 43.1% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.